OpenURL Connection Search

Select item for more details and to access through your institution.

Effect of initial combination therapy with sitagliptin and metformin on β-cell function in patients with type 2 diabetes.
Published in:
Diabetes, Obesity & Metabolism, 2012, v. 14, n. 1, p. 67, doi. 10.1111/j.1463-1326.2011.01492.x
By:
- Williams-Herman, D.;
- Xu, L.;
- Teng, R.;
- Golm, G. T.;
- Johnson, J.;
- Davies, M. J.;
- Kaufman, K. D.;
- Goldstein, B. J.
Publication type:
Article
A treatment strategy implementing combination therapy with sitagliptin and metformin results in superior glycaemic control versus metformin monotherapy due to a low rate of addition of antihyperglycaemic agents.
Published in:
Diabetes, Obesity & Metabolism, 2011, v. 13, n. 9, p. 841, doi. 10.1111/j.1463-1326.2011.01416.x
By:
- Olansky, L.;
- Reasner, C.;
- Seck, T. L.;
- Williams-Herman, D. E.;
- Chen, M.;
- Terranella, L.;
- Mehta, A.;
- Kaufman, K. D.;
- Goldstein, B. J.
Publication type:
Article
The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus.
Published in:
Diabetes, Obesity & Metabolism, 2011, v. 13, n. 7, p. 644, doi. 10.1111/j.1463-1326.2011.01390.x
By:
- Reasner, C.;
- Olansky, L.;
- Seck, T. L.;
- Williams-Herman, D. E.;
- Chen, M.;
- Terranella, L.;
- Johnson-Levonas, A. O.;
- Kaufman, K. D.;
- Goldstein, B. J.
Publication type:
Article
Effects of an 11 β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome.
Published in:
Diabetes, Obesity & Metabolism, 2011, v. 13, n. 6, p. 498, doi. 10.1111/j.1463-1326.2011.01375.x
By:
- Feig, P. U.;
- Shah, S.;
- Hermanowski-Vosatka, A.;
- Plotkin, D.;
- Springer, M. S.;
- Donahue, S.;
- Thach, C.;
- Klein, E. J.;
- Lai, E.;
- Kaufman, K. D.
Publication type:
Article
Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial.
Published in:
Diabetes, Obesity & Metabolism, 2011, v. 13, n. 2, p. 160, doi. 10.1111/j.1463-1326.2010.01334.x
By:
- Arechavaleta, R.;
- Seck, T.;
- Y. Chen;
- Krobot, K. J.;
- O'Neill, E. A.;
- Duran, L.;
- Kaufman, K. D.;
- Williams-Herman, D.;
- Goldstein, B. J.
Publication type:
Article
A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes.
Published in:
Diabetes, Obesity & Metabolism, 2010, v. 12, n. 6, p. 517, doi. 10.1111/j.1463-1326.2009.01188.x
By:
- Kipnes, M. S.;
- Hollander, P.;
- Fujioka, K.;
- Gantz, I.;
- Seck, T.;
- Erondu, N.;
- Shentu, Y.;
- Lu, K.;
- Suryawanshi, S.;
- Chou, M.;
- Johnson-Levonas, A. O.;
- Heymsfield, S. B.;
- Shapiro, D.;
- Kaufman, K. D.;
- Amatruda, J. M.
Publication type:
Article
Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes.
Published in:
Diabetes, Obesity & Metabolism, 2010, v. 12, n. 5, p. 442, doi. 10.1111/j.1463-1326.2010.01204.x
By:
- Williams-Herman, D.;
- Johnson, J.;
- Teng, R.;
- Golm, G.;
- Kaufman, K. D.;
- Goldstein, B. J.;
- Amatruda, J. M.
Publication type:
Article
Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes.
Published in:
Diabetes, Obesity & Metabolism, 2010, v. 12, n. 3, p. 252, doi. 10.1111/j.1463-1326.2009.01187.x
By:
- Aschner, P.;
- Katzeff, H. L.;
- Guo, H.;
- Sunga, S.;
- Williams-Herman, D.;
- Kaufman, K. D.;
- Goldstein, B. J.
Publication type:
Article
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes.
Published in:
Diabetes, Obesity & Metabolism, 2010, v. 12, n. 2, p. 167, doi. 10.1111/j.1463-1326.2009.01173.x
By:
- Vilsbøll, T.;
- Rosenstock, J.;
- Yki-Järvinen, H.;
- Cefalu, W. T.;
- Chen, Y.;
- Luo, E.;
- Musser, B.;
- Andryuk, P. J.;
- Ling, Y.;
- Kaufman, K. D.;
- Amatruda, J. M.;
- Engel, S. S.;
- Katz, L.
Publication type:
Article
Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency.
Published in:
Diabetes, Obesity & Metabolism, 2008, v. 10, n. 7, p. 545, doi. 10.1111/j.1463-1326.2008.00914.x
By:
- Chan, J. C. N.;
- Scott, R.;
- Arjona Ferreira, J. C.;
- Sheng, D.;
- Gonzalez, E.;
- Davies, M. J.;
- Stein, P. P.;
- Kaufman, K. D.;
- Amatruda, J. M.;
- Williams-Herman, D.
Publication type:
Article
A comparison of glycaemic effects of sitagliptin and sulfonylureas in elderly patients with type 2 diabetes mellitus.
Published in:
International Journal of Clinical Practice, 2015, v. 69, n. 6, p. 626, doi. 10.1111/ijcp.12607
By:
- Shankar, R. R.;
- Xu, L.;
- Golm, G. T.;
- O'Neill, E. A.;
- Goldstein, B. J.;
- Kaufman, K. D.;
- Engel, S. S.
Publication type:
Article
Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naïve patients with type 2 diabetes.
Published in:
International Journal of Clinical Practice, 2011, v. 65, n. 9, p. 930, doi. 10.1111/j.1742-1241.2011.02749.x
By:
- Pérez-Monteverde, A.;
- Seck, T.;
- Xu, L.;
- Lee, M. A.;
- Sisk, C. M.;
- Williams-Herman, D. E.;
- Engel, S. S.;
- Kaufman, K. D.;
- Goldstein, B. J.
Publication type:
Article
Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of β-cell function in patients with type 2 diabetes.
Published in:
International Journal of Clinical Practice, 2011, v. 65, n. 2, p. 154, doi. 10.1111/j.1742-1241.2010.02589.x
By:
- Yoon, K. H.;
- Shockey, G. R.;
- Teng, R.;
- Golm, G. T.;
- Thakkar, P. R.;
- Meehan, A. G.;
- Williams-Herman, D. E.;
- Kaufman, K. D.;
- Amatruda, J. M.;
- Steinberg, H.
Publication type:
Article
Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis.
Published in:
International Journal of Clinical Practice, 2010, v. 64, n. 7, p. 984, doi. 10.1111/j.1742-1241.2010.02382.x
By:
- Engel, S. S.;
- Williams-Herman, D. E.;
- Golm, G. T.;
- Clay, R. J.;
- Machotka, S. V.;
- Kaufman, K. D.;
- Goldstein, B. J.
Publication type:
Article
Efficacy and safety of initial combination treatment with sitagliptin and pioglitazone-a factorial study.
Published in:
Diabetes, Obesity & Metabolism, 2014, v. 16, n. 3, p. 223, doi. 10.1111/dom.12194
By:
- Henry, R. R.;
- Staels, B.;
- Fonseca, V. A.;
- Chou, M. Z.;
- Teng, R.;
- Golm, G. T.;
- Langdon, R. B.;
- Kaufman, K. D.;
- Steinberg, H.;
- Goldstein, B. J.
Publication type:
Article
Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function.
Published in:
Diabetes, Obesity & Metabolism, 2013, v. 15, n. 12, p. 1101, doi. 10.1111/dom.12145
By:
- Alba, M.;
- Ahrén, B.;
- Inzucchi, S. E.;
- Guan, Y.;
- Mallick, M.;
- Xu, L.;
- O'Neill, E. A.;
- Williams‐Herman, D. E.;
- Kaufman, K. D.;
- Goldstein, B. J.
Publication type:
Article
Efficacy and safety of initial combination therapy with sitagliptin and pioglitazone in patients with type 2 diabetes: a 54-week study.
Published in:
Diabetes, Obesity & Metabolism, 2012, v. 14, n. 8, p. 745, doi. 10.1111/j.1463-1326.2012.01594.x
By:
- Yoon, K. H.;
- Steinberg, H.;
- Teng, R.;
- Golm, G. T.;
- Lee, M.;
- O'Neill, E. A.;
- Kaufman, K. D.;
- Goldstein, B. J.
Publication type:
Article
Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes.
Published in:
Diabetes, Obesity & Metabolism, 2012, v. 14, n. 5, p. 409, doi. 10.1111/j.1463-1326.2011.01530.x
By:
- Wainstein, J.;
- Katz, L.;
- Engel, S. S.;
- Xu, L.;
- Golm, G. T.;
- Hussain, S.;
- O'Neill, E. A.;
- Kaufman, K. D.;
- Goldstein, B. J.
Publication type:
Article
Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study.
Published in:
International Journal of Clinical Practice, 2010, v. 64, n. 5, p. 562, doi. 10.1111/j.1742-1241.2010.02353.x
By:
- Seck, T.;
- Nauck, M.;
- Sheng, D.;
- Sunga, S.;
- Davies, M. J.;
- Stein, P. P.;
- Kaufman, K. D.;
- Amatruda, J. M.
Publication type:
Article
A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study.
Published in:
International Journal of Obesity, 2010, v. 34, n. 8, p. 1243, doi. 10.1038/ijo.2010.38
By:
- Proietto, J.;
- Rissanen, A.;
- Harp, J. B.;
- Erondu, N.;
- Yu, Q.;
- Suryawanshi, S.;
- Jones, M. E.;
- Johnson-Levonas, A. O.;
- Heymsfield, S. B.;
- Kaufman, K. D.;
- Amatruda, J. M.
Publication type:
Article
A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study.
Published in:
International Journal of Obesity, 2010, v. 34, n. 5, p. 919, doi. 10.1038/ijo.2010.21
By:
- Aronne, L. J.;
- Tonstad, S.;
- Moreno, M.;
- Gantz, I.;
- Erondu, N.;
- Suryawanshi, S.;
- Molony, C.;
- Sieberts, S.;
- Nayee, J.;
- Meehan, A. G.;
- Shapiro, D.;
- Heymsfield, S. B.;
- Kaufman, K. D.;
- Amatruda, J. M.
Publication type:
Article

Found: 21